These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14908363)

  • 41. Comparative effects between aminoazotoluene benzoquinone and streptomycin and between conteben and Japanese thiosemicarbazon in the experimental tuberculosis of mice.
    FURUTA M
    Sci Rep Res Inst Tohoku Univ Med; 1955 Mar; 6(2):233-40. PubMed ID: 13246667
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pathological-anatomical contribution to the course of infectious hepatitis in patients with pulmonary tuberculosis under conteben therapy].
    VOLLHABER HH
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 107(3):194-208. PubMed ID: 12977707
    [No Abstract]   [Full Text] [Related]  

  • 43. Tibione in pulmonary tuberculosis.
    ORREGO PUELMA H; ZANOLLI GRANELLO M; OLMEDO CRUZ R
    Dis Chest; 1953 Jan; 23(1):. PubMed ID: 12998453
    [No Abstract]   [Full Text] [Related]  

  • 44. [Studies on the concentration of PAS and TB 1 in the pleural effusion while undergoing respective treatment. II. On TB 1 (conteben)].
    KAWAI K
    Kekkaku; 1952 Aug; 27(8):397-401. PubMed ID: 13023835
    [No Abstract]   [Full Text] [Related]  

  • 45. Tibione in the treatment of pulmonary tuberculosis.
    COHEN SS; FROST RH; YUE WY
    Dis Chest; 1953 May; 23(5):507-17. PubMed ID: 13043508
    [No Abstract]   [Full Text] [Related]  

  • 46. Depression of coproporphyrin excretion by amithiozone.
    ZIEVE L; FALK A
    J Lab Clin Med; 1953 Sep; 42(3):454-8. PubMed ID: 13085036
    [No Abstract]   [Full Text] [Related]  

  • 47. [The relation of in vitro conteben sensitivity to conteben therapy; a study on conteben resistant tuberculosis strains].
    VELTMAN G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 106(5):413-20. PubMed ID: 14925075
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of TB I/698].
    DAHL RH
    Tidsskr Nor Laegeforen; 1951 Mar; 71(5):141-2. PubMed ID: 14835568
    [No Abstract]   [Full Text] [Related]  

  • 49. Amithiozone treatment of pulmonary tuberculosis; a pilot study of 21 patients.
    SANDHAUS HS; JENKINS DE; BURDON KL; HALPERT B
    Am Rev Tuberc; 1951 Aug; 64(2):170-81. PubMed ID: 14847147
    [No Abstract]   [Full Text] [Related]  

  • 50. Observations on the effect of amithiozone (tibione) in selected tuberculous pulmonary lesions.
    CHILDRESS WG; NORMAN JW; OTT RH; SPAIN DM
    Am Rev Tuberc; 1952 Jun; 65(6):692-708. PubMed ID: 14924192
    [No Abstract]   [Full Text] [Related]  

  • 51. [The effect of TB I/698 (conteben) on the excretion of ammonia, of fixed bases and of chlorine in urine of tuberculous children].
    HUNGERLAND H; KOSTER R; WALTHER M
    Klin Wochenschr; 1952 Jun; 30(23-24):562-3. PubMed ID: 12981833
    [No Abstract]   [Full Text] [Related]  

  • 52. Disturbance in carbohydrate metabolism associated with amithiozone therapy.
    ESCOVITZ WE
    Am Rev Tuberc; 1952 Sep; 66(3):373-7. PubMed ID: 14952724
    [No Abstract]   [Full Text] [Related]  

  • 53. [Present status of tuberculosis therapy with conteben, a substance of the thiosemicarbazones group].
    Rev Bras Tuberc Doencas Torac; 1950; 18(128):173-89. PubMed ID: 14781490
    [No Abstract]   [Full Text] [Related]  

  • 54. The treatment of pulmonary tuberculosis in Kenya Africans with thiacetazone.
    HAYNES WS
    East Afr Med J; 1952 Sep; 29(9):339-55. PubMed ID: 13010149
    [No Abstract]   [Full Text] [Related]  

  • 55. Agranulocytosis due to amithiozone therapy.
    PREHEIM DV; PECK ME
    Am Rev Tuberc; 1952 Mar; 65(3):339-43. PubMed ID: 14903501
    [No Abstract]   [Full Text] [Related]  

  • 56. The hepatic toxicity of amithiozone.
    FALK A; ZIEVE L; TUCKER WB; HANSON M
    Am Rev Tuberc; 1951 Aug; 64(2):159-69. PubMed ID: 14847146
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of serum from patients treated with conteben upon growth of the tubercle bacillus. III. The behavior of bacteria resistant to conteben; an indirect method of determining conteben blood levels].
    GEKS FJ
    Z Hyg Infektionskr; 1951; 132(2):162-72. PubMed ID: 14836997
    [No Abstract]   [Full Text] [Related]  

  • 58. [Studies on the metabolism of the tubercle bacillus following conteben administration with the aid of Warburg's method; contribution to the problem of virulence change following thiosemicarbazone administration].
    VELTMAN G; MIETHKE K
    Arztl Wochensch; 1953 Mar; 8(12):276-80. PubMed ID: 13057788
    [No Abstract]   [Full Text] [Related]  

  • 59. [Resistance modifications of the terminal vessels in skin tuberculosis under conteben and high dosage vitamin D2 therapy].
    GEHRELS PE; HEITE HJ; KALKOFF KW
    Klin Wochenschr; 1951 Jul; 29(27/28):483. PubMed ID: 14862094
    [No Abstract]   [Full Text] [Related]  

  • 60. [Conteben therapy in childhood tuberculosis].
    RUSS E
    Kinderarztl Prax; 1950; 18(11-12):521-5. PubMed ID: 14814791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.